692 related articles for article (PubMed ID: 33437907)
1. Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Memel ZN; Arvind A; Moninuola O; Philpotts L; Chung RT; Corey KE; Simon TG
Hepatol Commun; 2021 Jan; 5(1):133-143. PubMed ID: 33437907
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose-response analysis of cohort studies with one million participants.
Bhagavathula AS; Woolf B; Rahmani J; Vidyasagar K; Tesfaye W
Eur J Clin Pharmacol; 2022 Apr; 78(4):547-555. PubMed ID: 35039907
[TBL] [Abstract][Full Text] [Related]
3. Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.
Simon TG; Ma Y; Ludvigsson JF; Chong DQ; Giovannucci EL; Fuchs CS; Meyerhardt JA; Corey KE; Chung RT; Zhang X; Chan AT
JAMA Oncol; 2018 Dec; 4(12):1683-1690. PubMed ID: 30286235
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Does aspirin reduce the incidence, recurrence, and mortality of hepatocellular carcinoma? A GRADE-assessed systematic review and dose-response meta-analysis.
Ma S; Qu G; Sun C; Liu H; Jiang Y; Li N; Wu B; Gao J; Feng L; Xie P; Xia W; Kim NH; Lowe S; Bentley R; Zhu Y; Zhou Q; Sun Y
Eur J Clin Pharmacol; 2023 Jan; 79(1):39-61. PubMed ID: 36334108
[TBL] [Abstract][Full Text] [Related]
7. Regular Aspirin Use Is Associated with a Reduced Risk of Hepatocellular Carcinoma (HCC) in Chronic Liver Disease: a Systematic Review and Meta-analysis.
Tan JL; Sidhu-Brar S; Woodman R; Chinnaratha MA
J Gastrointest Cancer; 2023 Jun; 54(2):325-331. PubMed ID: 35717551
[TBL] [Abstract][Full Text] [Related]
8. Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis.
Kennedy OJ; Roderick P; Buchanan R; Fallowfield JA; Hayes PC; Parkes J
BMJ Open; 2017 May; 7(5):e013739. PubMed ID: 28490552
[TBL] [Abstract][Full Text] [Related]
9. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
[TBL] [Abstract][Full Text] [Related]
10. Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma.
Tan RZH; Lockart I; Abdel Shaheed C; Danta M
Aliment Pharmacol Ther; 2021 Aug; 54(4):356-367. PubMed ID: 34247393
[TBL] [Abstract][Full Text] [Related]
11. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
12. Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants.
Wang S; Yu Y; Ryan PM; Dang M; Clark C; Kontogiannis V; Rahmani J; Varkaneh HK; Salehisahlabadi A; Day AS; Zhang Y
Pharmacol Res; 2020 Jan; 151():104585. PubMed ID: 31816436
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.
Sahasrabuddhe VV; Gunja MZ; Graubard BI; Trabert B; Schwartz LM; Park Y; Hollenbeck AR; Freedman ND; McGlynn KA
J Natl Cancer Inst; 2012 Dec; 104(23):1808-14. PubMed ID: 23197492
[TBL] [Abstract][Full Text] [Related]
14. Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis.
Arvind A; Memel ZN; Philpotts LL; Zheng H; Corey KE; Simon TG
Metabolism; 2021 Jul; 120():154780. PubMed ID: 33891949
[TBL] [Abstract][Full Text] [Related]
15. Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials.
Kraglund F; Christensen DH; Eiset AH; Villadsen GE; West J; Jepsen P
Hepatol Commun; 2023 Jan; 7(1):e0013. PubMed ID: 36633465
[TBL] [Abstract][Full Text] [Related]
16. Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection.
Lee TY; Hsu YC; Tseng HC; Lin JT; Wu MS; Wu CY
Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2784-2792.e7. PubMed ID: 32360983
[TBL] [Abstract][Full Text] [Related]
17. NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project.
Petrick JL; Sahasrabuddhe VV; Chan AT; Alavanja MC; Beane-Freeman LE; Buring JE; Chen J; Chong DQ; Freedman ND; Fuchs CS; Gaziano JM; Giovannucci E; Graubard BI; Hollenbeck AR; Hou L; Jacobs EJ; King LY; Koshiol J; Lee IM; Linet MS; Palmer JR; Purdue MP; Rosenberg L; Schairer C; Sesso HD; Sigurdson AJ; Wactawski-Wende J; Zeleniuch-Jacquotte A; Campbell PT; McGlynn KA
Cancer Prev Res (Phila); 2015 Dec; 8(12):1156-62. PubMed ID: 26391917
[TBL] [Abstract][Full Text] [Related]
18. Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis.
Bravi F; Bosetti C; Tavani A; Gallus S; La Vecchia C
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1413-1421.e1. PubMed ID: 23660416
[TBL] [Abstract][Full Text] [Related]
19. Aspirin Use and the Risk of Hepatocellular Carcinoma: A Meta-analysis.
Wang Y; Wang M; Liu C; Wang W; Shi J; Dang S
J Clin Gastroenterol; 2022 Aug; 56(7):e293-e302. PubMed ID: 35316225
[TBL] [Abstract][Full Text] [Related]
20. Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults.
Hwang IC; Chang J; Kim K; Park SM
Sci Rep; 2018 Mar; 8(1):4968. PubMed ID: 29563592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
